In PFF's 2016 NFL re-draft, the New York Giants avoid a costly mistake by passing on cornerback bust Eli Apple.

The Washington Nationals selected Oklahoma high school shortstop Eli Willits on Sunday night with the No. 1 pick in Major League Baseball's amateur draft in a selection seen by some as a surprise.

The new Chase Sapphire Reserve brings major upgrades, including $250 in Apple Music & TV+ credits — perfect for travelers and Apple fans.

Eli Lilly's valuation might be a significant stumbling block for some investors. If the stock fails to meet the market's lofty expectations, its shares will plummet.

A nearly three-year-old AI startup has caught Meta’s attention, and reportedly Apple’s too. Meta spoke with AI search engine Perplexity about a potential acquisition, although a deal was not ...

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.

Taking a look back at this week’s news and headlines from Apple; iPhone 17 and iPhone 17 Pro launch dates, MacBook Pro upgrade details, iPad multitasking, Apple challenges AI assumptions, and ...

Former NFL quarterbacks Tom Brady and Eli Manning reignited their rivalry in WWE fashion during a walkout at Fanatics Fest in New York City. Brady and Manning were among a number of athletes to ...

Are you a student who is struggling to convince your parents to buy you a Mac for college? Apple has come up with a humorous solution for you. Apple today shared The Parent Presentation, which ...

Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the drugmaker’s latest investment in an experimental medicine that could fuel its long-term ...

Shares of Verve Therapeutics skyrocketed 75% Tuesday morning after Eli Lilly announced that it would acquire the gene-editing startup for about $1.3 billion.

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.